CONCORD BIOTECH
Back to Cashflow Statement
|
CONCORD BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-99 Cr | ₹-99 Cr | ₹-85 Cr | ₹-100 Cr | ₹31 Cr |
What is the latest Cash Flow from Financing Activities ratio of CONCORD BIOTECH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-99 Cr |
| Mar2024 | ₹-99 Cr |
| Mar2023 | ₹-85 Cr |
| Mar2022 | ₹-100 Cr |
| Mar2021 | ₹31 Cr |
How is Cash Flow from Financing Activities of CONCORD BIOTECH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-99 Cr | Negative | |
| Mar2024 | ₹-99 Cr | Negative | |
| Mar2023 | ₹-85 Cr | Negative | |
| Mar2022 | ₹-100 Cr | Negative | |
| Mar2021 | ₹31 Cr | - | |
Compare Cash Flow from Financing Activities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,300.4 Cr | 5.9% | 8.2% | -34.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,938.0 Cr | -0.6% | -3.7% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 2.8% | 0.7% | -0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,385.0 Cr | 2.4% | 2.1% | 40.8% | Stock Analytics | |
| CIPLA | ₹111,220.0 Cr | 0.1% | 2.2% | -5.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,899.0 Cr | 0.5% | -1.9% | 2.2% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 5.9% |
8.2% |
-34.7% |
| SENSEX | -1% |
-5% |
-9.2% |
You may also like the below Video Courses